Literature DB >> 26209622

Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways.

Elena Izquierdo1, Víctor Delgado Cuevas1, Salvador Fernández-Arroyo2, Marta Riera-Borrull2, Emmanuel Orta-Zavalza1, Jorge Joven2, Eduardo Rial1, Angel L Corbi1, María M Escribese3.   

Abstract

Macrophages integrate information from the tissue microenvironment and adjust their effector functions according to the prevalent extracellular stimuli. Therefore, macrophages can acquire a variety of activation (polarization) states, and this functional plasticity allows the adequate initiation, regulation, and resolution of inflammatory responses. Modulation of the glucose metabolism contributes to the macrophage adaptation to the surrounding cytokine milieu, as exemplified by the distinct glucose catabolism of macrophages exposed to LPS/IFN-γ or IL-4. To dissect the acquisition of macrophage effector functions in the absence of activating cytokines, we assessed the bioenergetic profile of macrophages generated in the presence of GM-CSF (GM-MØ) or M-CSF (M-MØ), which do not release pro- or anti-inflammatory cytokines unless subjected to additional activating stimuli. Compared to M-MØ, GM-MØ displayed higher oxygen consumption rate and aerobic glycolysis (extracellular acidification rate [ECAR]), as well as higher expression of genes encoding glycolytic enzymes. However, M-MØ exhibited a significantly higher oxygen consumption rate/ECAR ratio. Surprisingly, whereas aerobic glycolysis positively regulated IL1B, TNF, and INHBA mRNA expression in both macrophage subtypes, mitochondrial respiration negatively affected IL6, IL1B, TNF, and CXCL10 mRNA expression in M-MØ. The physiological significance of these results became evident under low oxygen tensions, as hypoxia enhanced ECAR in M-MØ via HIF-1α and HIF-2α, increased expression of glycolytic enzymes and GM-MØ-specific genes, and diminished expression of M-MØ-associated genes. Therefore, our data indicate that GM-MØ and M-MØ display distinct bioenergetic profiles, and that hypoxia triggers a transcriptomic switch in macrophages by promoting a HIF-1α/HIF-2α-dependent increase in ECAR.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26209622     DOI: 10.4049/jimmunol.1403045

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.

Authors:  M Qorraj; H Bruns; M Böttcher; L Weigand; D Saul; A Mackensen; R Jitschin; D Mougiakakos
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

2.  Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.

Authors:  Anitha Krishnan; Fei Fei; Alexander Jones; Patricia Busto; Ann Marshak-Rothstein; Bruce R Ksander; Meredith Gregory-Ksander
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

3.  Differential Regulation of Macrophage Glucose Metabolism by Macrophage Colony-stimulating Factor and Granulocyte-Macrophage Colony-stimulating Factor: Implications for 18F FDG PET Imaging of Vessel Wall Inflammation.

Authors:  Sina Tavakoli; John D Short; Kevin Downs; Huynh Nga Nguyen; Yanlai Lai; Wei Zhang; Paul Jerabek; Beth Goins; Mehran M Sadeghi; Reto Asmis
Journal:  Radiology       Date:  2016-11-16       Impact factor: 11.105

4.  Programmed mitophagy is essential for the glycolytic switch during cell differentiation.

Authors:  Lorena Esteban-Martínez; Elena Sierra-Filardi; Rebecca S McGreal; María Salazar-Roa; Guillermo Mariño; Esther Seco; Sylvère Durand; David Enot; Osvaldo Graña; Marcos Malumbres; Ales Cvekl; Ana María Cuervo; Guido Kroemer; Patricia Boya
Journal:  EMBO J       Date:  2017-05-02       Impact factor: 11.598

5.  Changes in macrophage function modulated by the lipid environment.

Authors:  Michael R Williams; David M Cauvi; Isabel Rivera; Dennis Hawisher; Antonio De Maio
Journal:  Innate Immun       Date:  2016-03-07       Impact factor: 2.680

Review 6.  Regulation of macrophage immunometabolism in atherosclerosis.

Authors:  Graeme J Koelwyn; Emma M Corr; Ebru Erbay; Kathryn J Moore
Journal:  Nat Immunol       Date:  2018-05-18       Impact factor: 25.606

7.  Conservation of Intracellular Pathogenic Strategy among Distantly Related Cryptococcal Species.

Authors:  Joudeh B Freij; Man Shun Fu; Carlos M De Leon Rodriguez; Amanda Dziedzic; Anne E Jedlicka; Quigly Dragotakes; Diego C P Rossi; Eric H Jung; Carolina Coelho; Arturo Casadevall
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

8.  Interleukin-34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony-Stimulating Factor Receptor.

Authors:  Katrien Van Raemdonck; Sadiq Umar; Karol Palasiewicz; Michael V Volin; Hatem A Elshabrawy; Bianca Romay; Chandana Tetali; Azam Ahmed; M Asif Amin; Ryan K Zomorrodi; Nadera Sweiss; Shiva Shahrara
Journal:  Arthritis Rheumatol       Date:  2021-09-22       Impact factor: 10.995

Review 9.  Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins.

Authors:  Chiara Elisabeth Geyer; Lynn Mes; Melissa Newling; Jeroen den Dunnen; Willianne Hoepel
Journal:  Cells       Date:  2021-05-12       Impact factor: 6.600

10.  PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure.

Authors:  Xiaoshuang Zhou; Yidong Li; Yaqiu Ji; Tian Liu; Ninghui Zhao; Jiefeng He; Jia Yao
Journal:  J Clin Transl Hepatol       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.